X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (86) 86
index medicus (76) 76
female (57) 57
hematology (56) 56
oncology (56) 56
middle aged (55) 55
male (52) 52
aged (51) 51
adult (42) 42
aged, 80 and over (36) 36
treatment outcome (32) 32
acute myeloid-leukemia (29) 29
article (26) 26
leukemia, myeloid, acute - drug therapy (26) 26
prognosis (26) 26
cancer (24) 24
leukemia (18) 18
myelodysplastic syndromes (18) 18
therapy (18) 18
acute myelogenous leukemia (17) 17
acute myeloid leukemia (17) 17
antineoplastic combined chemotherapy protocols - therapeutic use (17) 17
myelodysplastic syndromes - drug therapy (16) 16
chemotherapy (15) 15
survival rate (15) 15
abridged index medicus (14) 14
azacitidine - analogs & derivatives (14) 14
leukemia, myeloid, acute - mortality (14) 14
leukemia, myeloid, acute - pathology (14) 14
remission induction (14) 14
disease-free survival (13) 13
dose-response relationship, drug (13) 13
leukemia, myeloid, acute - genetics (13) 13
antineoplastic agents - therapeutic use (12) 12
young adult (12) 12
aml (11) 11
azacitidine - administration & dosage (11) 11
care and treatment (11) 11
cytarabine - administration & dosage (11) 11
decitabine (11) 11
diagnosis (11) 11
hematology, oncology and palliative medicine (11) 11
hemic and lymphatic diseases (11) 11
myelodysplastic syndrome (11) 11
patients (11) 11
research (11) 11
antineoplastic agents - adverse effects (10) 10
azacitidine (10) 10
cells (10) 10
leukemia, myeloid, acute - diagnosis (10) 10
leukemia, myeloid, acute - therapy (10) 10
mutation (10) 10
myelodysplastic syndromes - mortality (10) 10
older patients (10) 10
recurrence (10) 10
risk factors (10) 10
survival (10) 10
adolescent (9) 9
animals (9) 9
cytarabine (9) 9
kaplan-meier estimate (9) 9
mds (9) 9
retrospective studies (9) 9
risk myelodysplastic syndrome (9) 9
analysis (8) 8
clinical trials (8) 8
clinical trials and observations (8) 8
drug administration schedule (8) 8
follow-up studies (8) 8
risk (8) 8
transplantation (8) 8
acute disease (7) 7
age (7) 7
antimetabolites, antineoplastic - therapeutic use (7) 7
antineoplastic agents - administration & dosage (7) 7
azacitidine - therapeutic use (7) 7
disease progression (7) 7
drug therapy (7) 7
elderly-patients (7) 7
myelodysplastic syndromes - pathology (7) 7
relapse (7) 7
scoring system (7) 7
survival analysis (7) 7
acute promyelocytic leukemia (6) 6
bone marrow (6) 6
clinical trials as topic (6) 6
drug resistance, neoplasm (6) 6
health aspects (6) 6
hematopoietic stem cell transplantation (6) 6
induction (6) 6
maximum tolerated dose (6) 6
medical research (6) 6
mortality (6) 6
mutations (6) 6
remission (6) 6
stem cells (6) 6
trial (6) 6
tumors (6) 6
bone-marrow (5) 5
cell biology (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 4790 - 4790
Abstract Acute myelogenous leukemia (AML) is a fatal disease with dismal outcomes. Despite aggressive chemotherapy regimens, most patients relapse and... 
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 12/2014, Volume 12, Issue 12, pp. 11 - 14
Journal Article
Expert Opinion on Drug Discovery, ISSN 1746-0441, 11/2016, Volume 11, Issue 11, pp. 1029 - 1032
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 903 - 903
Abstract Background: Prognosis for older patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) is poor, with lower response rates and shorter... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 2555 - 2555
Abstract The remissions achieved using autologous T-cells expressing chimeric antigen receptors (CARs) in patients with advanced B cell leukemia and lymphomas... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 297 - 297
Abstract Introduction: Somatic mutations are common in MDS and mutation profiling is becoming increasingly standard as part of the initial diagnostic... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4332 - 4332
Abstract Background Lower-risk (LR) MDS (Low/Int-1 per International Prognostic Scoring System (IPSS)) are a heterogeneous group of disorders characterized... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 765 - 765
Abstract Acute myeloid leukemia (AML) is a disease with a high incidence of relapse and mortality. Relapse is attributed to the inability of current... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4322 - 4322
Abstract Introduction While lenalidomide (LEN) is the standard of care for treatment of red blood cell (RBC) transfusion-dependent (TD) lower-risk... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 1696 - 1696
Abstract Background: The majority of MDS patients (pts) have anemia and are treated initially with ESAs. Particularly for lower-risk MDS pts (International... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 714 - 714
Abstract + The first four authors contributed equally to this project. Myelodysplastic syndromes (MDS) are a group of blood cell disorders, characterized by... 
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 1667 - 1667
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14_Supplement, pp. 3992 - 3992
Acute myeloid leukemia (AML) is incurable in the majority of patients. While allogeneic stem cell transplantation remains the most effective therapy for AML to... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4321 - 4321
Abstract Introduction Recurrent somatic mutations in SF3B1, a gene encoding a spliceosome component, have been identified in patients (pts) with... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 911 - 911
Background: Pracinostat (PR) is a potent oral inhibitor of histone deacetylases (HDAC's), selective for class I, II and IV isoforms. A pilot phase Ib study of... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 102 - 102
Abstract Background: Multiple studies have demonstrated the modest efficacy of low-dose cytarabine (LDAC) in older patients (≥65 years) with Acute Myeloid... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.